1/17/2022 | 3004900002 | MEDICINES PACKED IN PACKAGES ARE NOT SUBJECT TO SALE OR RESALE, HAVE NO COMMERCIAL VALUE AND ARE IMPORTED EXCLUSIVELY FOR CONDUCTING CLINICAL TESTS ACCORDING TO PROTOCOL No. EFC13738 ELIKIDS. | 1.56 | 45999.3 | Ireland | UNKNOWN | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
1/27/2022 | 3004900002 | MEDICINES (OTHER THAN GOODS OF HEADING 3002, 3005 OR 3006), PREPACKED FOR CLINICAL TRIALS ACCORDING TO PROTOCOL No. C3601002, PACKED IN ISOTHERMAL BOX WITH INSERTED THERMAL SENSORS: | 3.5 | 1827.5 | Ireland | Unknown | PFIZER INHOVATSIYA LLC |
1/19/2022 | 3004900002 | Medicinal preparation for medical care for life indications: Katrio (Ivakafor, thezakaftor, electricacaftor), tablets, 75 mg / 50mg / 100 mg No. 56, 56 tablets, packaging - 1 Packaging, W058636C series is valid to 11.2022, actants | 0.1 | 13659.9 | Ireland | MOSCOW RUSSIA | SPECTR LINE LLC |
1/18/2022 | 3004320008 | MEDICINAL PRODUCT CONTAINING CORTICOSTEROID HORMONES, FOR RETAIL, (VED BF): BECLAZONE ECO LIGHT BREATHING (BECLOMETASONE) AEROSOL FOR INHALATION DOSE ACTIVATED BY INHALATION 250 MCG/DOSE (BOTTLE+INHALATOR) 200 | 256.6 | 32907.5 | Ireland | MOSCOW RUSSIA | TEVA LLC |
1/17/2022 | 3006109000 | MEDICAL PRODUCTS: DEVICE FOR CLOSURE OF ARTERIAL ACCESS PERCLOSE PROGLIDE. OKP CODE 943110. OKPD2: 32.50.13.190 | 132.72 | 40667.2 | Ireland | MOSCOW RUSSIA | ABBOTT LABORATORIZ LLC |
1/30/2022 | 3002150000 | MEDICINES (MODIFIED IMMUNOLOGICAL PRODUCTS) INTENDED FOR CLINICAL STUDIES ACCORDING TO PROTOCOL BO40729, NOT ETHYL ALCOHOL, NOT FOR THERAPEUTIC USE, NOT FOR VETERINARY, NOT FOR SALE, (PACK B | 1.09 | 138987.2 | Ireland | SHEREMETIEVO 2 MOSCOW RUSSIA | REPRESENTATIVE OFFICE OF THE LLC F HOFFMANN LA ROCH LIMITED |
1/27/2022 | 3002150000 | MEDICINES (MODIFIED IMMUNOLOGICAL PRODUCTS) INTENDED FOR CLINICAL STUDIES ACCORDING TO PROTOCOL BO40729, NOT ETHYL ALCOHOL, NOT FOR THERAPEUTIC USE, NOT FOR VETERINARY, NOT FOR SALE, (PACK B | 9.3 | 22973 | Ireland | SHEREMETIEVO 2 MOSCOW RUSSIA | REPRESENTATIVE OFFICE OF THE LLC F HOFFMANN LA ROCH LIMITED |
1/27/2022 | 3002150000 | DRUG FOR CLINICAL STUDY ACCORDING TO PROTOCOL No. BCD-201-1 - KEYTRUDA , CONCENTRATE FOR PREPARING SOLUTION FOR INFUSION 100 MG/4 ML BOTTLE, CARDBOARD PACK. | 1.2 | 119260.9 | Ireland | RIGA | CJSC BIOCAD |
1/29/2022 | 3004900002 | MEDICINES, PREPACKED FOR CLINICAL TRIALS ACCORDING TO PROTOCOL No. C3601009, PACKED IN ISOTHERMAL BOX WITH INSERTED THERMAL SENSOR: | 18 | 199.55 | Ireland | Unknown | PFIZER INHOVATSIYA LLC |
1/13/2022 | 3004900008 | MEDICINES CONSISTING OF MIXED PRODUCTS FOR CLINICAL STUDIES ACCORDING TO PROTOCOL 20160275, NOT CONTAINING. HORMONES, ANTIBIOTICS, ETHYL ALCOHOL, NOT FOR VETERINARY, | 9 | 202034.5 | Ireland | LOS ANGELES AIRPORT | AMDZHEN LLC |